Modelos de datos seleccionados

Debe iniciar sesión para seleccionar modelos de datos para descargar o realizar un análisis.

10 Resultados de la búsqueda.
Relevancia Evaluación Nuevo primero Antiguo primero

Eligibility Criteria: CRF Wisconsin Madison

- 17/11/16 - 1 formulario, 4 itemgroups, 14 items, 1 idioma
Itemgroups: Header, Eligibility Criteria - Inclusion Criteria, Eligibility Criteria - Exclusion Criteria, undefined itemgroup
ODM Form derived from: https://ictr.wisc.edu/CaseReptTempt. Template Name: Eligibility Criteria. Case Report Form (CRF)/Source Document templates were created for University of Wisconsin-Madison researchers. These templates are consistent with the FDA's CDASH (Clinical Data Acquisition Standards Harmonization) standards. The CDASH standards identify those elements that should be captured on a Case Report Form (CRF). The forms serve only as templates, and must be edited to meet the study data collection needs as described in the protocol.

Eligibility Hypertension NCT02047019

- 1/9/15 - 1 formulario, 2 itemgroups, 14 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Monotherapy-Controlled Study of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Combination in Subjects With Essential Hypertension Inadequately Controlled on Candesartan Cilexetil; ODM derived from: https://clinicaltrials.gov/show/NCT02047019

Eligibility Head and Neck Cancer NCT01958515

- 31/8/15 - 1 formulario, 2 itemgroups, 11 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Immunologic Responses in HPV-Associated Carcinoma for Patients Receiving Chemoradiation; ODM derived from: https://clinicaltrials.gov/show/NCT01958515

Eligibility Essential Arterial Hypertension NCT02493322

- 31/8/15 - 1 formulario, 2 itemgroups, 15 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Efficacy and Safety of Olmesartan Associated With Chlorthalidone in Essential Arterial Hypertension Control; ODM derived from: https://clinicaltrials.gov/show/NCT02493322

Eligibility Diabetes Mellitus, Type 2 NCT01984606

- 31/8/15 - 1 formulario, 3 itemgroups, 15 items, 1 idioma
Itemgroups: Inclusion Criteria, Inclusion Criteria, Exclusion Criteria
Efficacy and Safety of Empagliflozin Versus Sitagliptin in Patients With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01984606

Eligibility Diabetes NCT02500706

- 31/8/15 - 1 formulario, 3 itemgroups, 9 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria, Inclusion Criteria
Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Adults With Type 1 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT02500706

Eligibility Diabetes Mellitus, Type 2 NCT02481596

- 31/8/15 - 1 formulario, 5 itemgroups, 19 items, 1 idioma
Itemgroups: Criteria, Inclusion Criteria, Exclusion Criteria, Inclusion Criteria, Exclusion Criteria
Family-Focused Mobile Health Intervention; ODM ODM derived from: https://clinicaltrials.gov/show/NCT02481596

Eligibility Diabetes Mellitus NCT01876485

- 31/8/15 - 1 formulario, 2 itemgroups, 14 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Point-of-care Health Literacy and Activation Information to Improve Diabetes Care; ODM derived from: https://clinicaltrials.gov/show/NCT01876485

Eligibility ´T Cell Lymphoma NCT02192021 - Eligibility Cutaneous T Cell Lymphoma NCT02192021

- 30/8/15 - 1 formulario, 3 itemgroups, 15 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria, Exclusion Criteria
Micro Needle Array-Doxorubicin (MNA-D) in Patients With Cutaneous T-cell Lymphoma (CTCL); ODM derived from: https://clinicaltrials.gov/show/NCT02192021

Eligibility Coronary Artery Disease NCT02327455

- 30/8/15 - 1 formulario, 2 itemgroups, 10 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Integrated RF and B-mode Deformation Analysis for 4D Stress Echocardiography; ODM derived from: https://clinicaltrials.gov/show/NCT02327455

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial